ArticleHeart (British Cardiac Society)2002
Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes.
Article in Heart (British Cardiac Society), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
French Registry of Acute Coronary Syndrome With or Without ST Elevation
French Cohort of Myocardial Infarction Evaluation
Who cites it
5 citing papers in PubMed, 33 citations in OpenAlex.
- How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England.International journal for equity in health · 2007Article
- A clearly visible V wave in the pulmonary artery pressure curve caused by severe mitral valve regurgitation.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2006Article
- The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention.The Canadian journal of cardiology · 2006Article
- Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need.International journal for equity in health · 2005Article
- Patients with acute coronary syndrome should start a statin while still in hospital.Heart (British Cardiac Society) · 2002Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 7 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt has been suggested that patients undergoing acute intervention for coronary syndromes may not receive adequate secondary prevention.
objectiveTo analyse the impact of availability and use of coronary interventions on the prescription of secondary prevention after acute coronary syndromes.
designAnalysis of a prospective multicentre register of patients admitted to hospital for acute coronary syndromes.
settingA 1999 pan-European survey in 390 hospitals. PATIENTS: 3092 patients admitted to hospital with acute coronary syndromes (including 777 for ST elevation myocardial infarction within 12 hours of onset).
main outcome measuresRates of prescription of aspirin and lipid lowering agents.
resultsPerformance of coronary angiography and percutaneous coronary interventions (PCI) during the hospital stay were independent predictors of prescription of aspirin at discharge (odds ratio (OR) 1.29 and 1.89, p = 0.053 and p < 0.0001, respectively). Lipid lowering agents were prescribed more often on discharge in patients admitted to hospitals with catheterisation laboratories than without (for infarction with ST elevation, 45% v 40% (NS); for other acute coronary syndromes, 46% v 36%; p < 0.05). Prescription rates were higher among patients undergoing coronary angiography or PCI than in those treated conservatively (for infarction with ST elevation, 49%, 53%, and 39%, p < 0.05; for other acute coronary syndromes, 50%, 54%, and 34%, p < 0.05). Logistic regression analysis showed that PCI was an independent predictor of prescription of lipid lowering agents at discharge (OR 1.48, p < 0.0002).
conclusionsContrary to expectations, invasive procedures for acute coronary syndromes are associated with higher rates of prescription of pharmacological secondary prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.